Journal articleCancer Res2025
FGFR2 Abrogation Intercepts Pancreatic Ductal Adenocarcinoma Development.
- Journal
- Cancer Res
- Published
- 1 June 2025
- Citations
- 5
- Type
- Article
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 7
- CSHL Cancer Center Support Grant P30CA045508↗
- Nrf2 Regulation of Ductal Pancreatic Cancer Etiology and Treatment Response R01CA188134↗
- (PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer R01CA190092↗
- Targeting aberrant enhancer landscapes in pancreatic cancer R01CA229699↗
- Preclinical Models for Cancer Therapeutic Development R50CA211506↗
- Pancreatic Cancer Detection Consortium U01CA210240↗
- CSHL-JAX Patient-Derived Models of Pancreatic Cancer as Systems for Investigating Tumor Heterogeneity U01CA224013↗